SOLIHULL HEALTHCARE PARTNERSHIP
GROVE SURGERY, 3 GROVE ROAD, SOLIHULLHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 63 | 75 | 84.0% | |
HF 4 | 2011 | 62 | 77 | 80.5% | |
HF 4 | 2012 | 64 | 83 | 77.1% | |
HF 4 | 2013 | 74 | 85 | 87.1% | |
HF004 | 2014 | 55 | 58 | 94.8% | |
HF004 | 2015 | 49 | 52 | 94.2% | |
HF004 | 2016 | 44 | 48 | 91.7% | |
HF004 | 2017 | 40 | 45 | 88.9% | |
HF004 | 2018 | 41 | 44 | 93.2% | |
HF004 | 2019 | 43 | 48 | 89.6% | |
HF004 | 2020 | 92 | 97 | 94.8% | |
HF006 | 2021 | 108 | 123 | 87.8% | |
HF006 | 2022 | 119 | 126 | 94.4% | |
HF006 | 2023 | 172 | 177 | 97.2% |